Forecast & Rating4 analysts currently cover Anixa Biosciences, of which 4 give a positive rating. The average price target is $10.00, about 171.7% upside from the current price of $3.68. Coverage is limited, so the data is for reference only. Data as of Jun 29, 2026; this does not constitute investment advice.
Jun 29, 2026Price forecast
$10.00167.45%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met0.0%
Stock price$3.68
Avg. target$10.0
High target$14
Low target$7
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.